Millstone Evans Group LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 191 shares of the company’s stock, valued at approximately $31,000.
Several other hedge funds have also added to or reduced their stakes in CLX. Brooklyn Investment Group lifted its position in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the period. Continuum Advisory LLC lifted its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the period. Asset Planning Inc bought a new position in Clorox in the fourth quarter valued at approximately $32,000. Halbert Hargrove Global Advisors LLC bought a new position in Clorox in the fourth quarter valued at approximately $36,000. Finally, BankPlus Trust Department bought a new stake in shares of Clorox during the 4th quarter valued at $40,000. Institutional investors own 78.53% of the company’s stock.
Clorox Trading Down 0.8 %
CLX opened at $143.75 on Tuesday. The stock has a market capitalization of $17.71 billion, a P/E ratio of 39.28, a P/E/G ratio of 2.62 and a beta of 0.45. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The firm’s fifty day simple moving average is $152.57 and its 200 day simple moving average is $159.59.
Clorox Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.39%. Clorox’s dividend payout ratio is currently 133.33%.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the company. Evercore ISI raised their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Wells Fargo & Company raised their target price on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. DA Davidson reduced their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Finally, Barclays upped their target price on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, Clorox currently has an average rating of “Hold” and an average price target of $159.62.
View Our Latest Stock Report on Clorox
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- 3 Fintech Stocks With Good 2021 Prospects
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- What Do S&P 500 Stocks Tell Investors About the Market?
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.